Articles by Disease (Syringomyelia)

Eph/ephrin Signaling as a Potential Therapeutic Target After Central Nervous System Injury

Journal: Current Pharmaceutical Design
Volume: 13
Page: 2507-2518
Author(s): J. Du, C. Fu and D.W. Sretavan

Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction

Journal: Current Pharmaceutical Design
Volume: 12
Page: 3467-3484
Author(s): Antonio Aversa, Roberto Bruzziches, Marcello Pili and Giovanni Spera

Back Pain in Children and Adolescents: Etiology, Clinical Approach and Treatment

Journal: Current Pediatric Reviews
Volume: 2
Page: 265-286
Author(s): Athanasios I. Tsirikos and Kosta Kalligeros

L-Acetylcarnitine: A Proposed Therapeutic Agent for Painful Peripheral Neuropathies

Journal: Current Neuropharmacology
Volume: 4
Page: 233-237
Author(s): S. Chiechio, A. Copani, F. Nicoletti and R. W. Gereau IV

Strategies to Create a Regenerating Environment for the Injured Spinal Cord

Journal: Current Pharmaceutical Design
Volume: 11
Page: 1267-1277
Author(s): Shulin Xiang, Weihong Pan and Abba J. Kastin

Cell Elimination as a Strategy for Repair in Acute Spinal Cord Injury

Journal: Current Pharmaceutical Design
Volume: 11
Page: 1237-1245
Author(s): Nurit Kalderon

Neuroprotection and Regeneration Strategies for Spinal Cord Repair

Journal: Current Pharmaceutical Design
Volume: 11
Page: 1211-1222
Author(s): Eve C. Tsai and Charles H. Tator

Neural Plasticity After Spinal Cord Injury

Journal: Current Pharmaceutical Design
Volume: 11
Page: 1441-1450
Author(s): Yuemin Ding, Abba J. Kastin and Weihong Pan

Research on the Possibility of Overcoming Traumatic Paraplegia and Its First Clinical Results

Journal: Current Pharmaceutical Design
Volume: 11
Page: 1421-1428
Author(s): Giorgio Brunelli

Pathophysiology of Blood-Spinal Cord Barrier in Traumatic Injury and Repair

Journal: Current Pharmaceutical Design
Volume: 11
Page: 1353-1389
Author(s): Hari Shanker Sharma